Tivic Health Systems Inc. has entered into a significant Securities Purchase Agreement with an investor on April 29, 2025. Under the agreement, Tivic will sell up to 8,400 shares of its newly designated Series B Non-Voting Convertible Preferred Stock, along with warrants to purchase common stock, for a total potential investment of $8.4 million. The sales will occur in multiple tranche closings, with a deadline for completion set for December 31, 2025. The agreement includes a Registration Rights Agreement, requiring Tivic to file a registration statement within 15 days to facilitate the resale of securities by the investor. However, investor conversions and warrant exercises are capped at 19.99% of Tivic's outstanding common stock as of the agreement date until stockholder approval is obtained.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。